Generation of Functioning Platelets from Mature Megakaryocytes Derived from CD34 + Umbilical Cord Blood Cells
Stem Cells and Development · 2024
DOI: 10.1089/scd.2024.0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells and Development, 2024. Verfasst von Zhiyong Zhong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzho…. Hauptthemen laut MEDLINE: Megakaryocytes, Fetal Blood, Antigens, CD34, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Clinically patients with thrombocytopenia are in urgent need of platelet transfusion, thus it is necessary to produce the platelets in large scale in vitro to meet the clinical needs. In this study, we developed efficient protocol to generate functioning platelets by differentiating umbilical cord blood (CB)-derived CD34+ cells into mature megakaryocytes. Under our condition, up to 85% of mature megakaryocytes were generated from CB-derived CD34+ cells, and over 75% CD42b+CD62p+ platelets were produced. The megakaryocytes at day 12 after the differentiation had the similar gene expression pattern to natural mature megakaryocytes, and AMPK and insulin signal pathway were activated to inhibit the apoptosis and benefit platelet release. There were up to 72% of the platelets that could bind with PAC1, which is the highest rate of CB CD34+ cell-derived platelets to play function in vitro to date. The recovery of hemostasis and coagulation was similar in thrombocytopenia mice injected with CB CD34+ cell-derived platelets and with human blood-derived platelets, respectively, and it is the first time to demonstrate that human CB CD34+ cell-derived platelets were functional in vivo. Therefore, our findings open a new avenue to provide an in vitro efficient approach to generate functional platelets for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou, P.R. China.
- Laboratory of Stem Cells and Translational Medicine, Institute for Clinical Medicine, the Second Affiliation Hospital of South China University of Technology, School of Medicine, South China University of Technology, Gu…
- Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, P.R. China.
- Department of Blood Transfusion, the Second Affiliated Hospital of South China University of Technology, School of Medicine, South China University of Technology, Guangzhou, P.R. China.
- The Innovation Centre of Ministry of Education for Development and Diseases, the Second Affiliated Hospital of South China University of Technology, School of Medicine, South China University of Technology, Guangzhou, C…
ORCID-Profile: Yuyou Duan
Zitieren
APA
Zhong, Z., Chen, C., Wang, N., Qiu, Y., Li, X., Liu, S., Wu, H., Tang, X., Fu, Y., Chen, Q., Guo, T., Wei, Y., & Duan, Y. (2024). Generation of Functioning Platelets from Mature Megakaryocytes Derived from CD34 + Umbilical Cord Blood Cells. Stem Cells and Development. https://doi.org/10.1089/scd.2024.0095
Vancouver
Zhong Z, Chen C, Wang N, Qiu Y, Li X, Liu S, et al. Generation of Functioning Platelets from Mature Megakaryocytes Derived from CD34 + Umbilical Cord Blood Cells. Stem Cells and Development. 2024. doi:10.1089/scd.2024.0095
BibTeX
@article{Zhong2024,
author = {Zhong, Zhiyong and Chen, Chuxin and Wang, Ning and Qiu, Yaqi and Li, Xiajing and Liu, Shoupei and Wu, Haibin and Tang, Xianglian and Fu, Yingjie and Chen, Qicong and Guo, Tingting and Wei, Yaming and Duan, Yuyou},
title = {Generation of Functioning Platelets from Mature Megakaryocytes Derived from CD34 + Umbilical Cord Blood Cells},
journal = {Stem Cells and Development},
year = {2024},
doi = {10.1089/scd.2024.0095}
}
EUVIMED